MedTrace Logo

Prevalence of Cholelithiasis with Umbilical Hernia

NCT06522308 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 278

Last updated 2025-01-27

No results posted yet for this study

Summary

Researchers aim to determine the exact prevalence and risk factors for the association of gallstones and umbilical hernia. Umbilical hernia is defined according to the European Hernia Society Classification for primary and incisional abdominal wall hernias as hernias occurring from 3 cm above to 3 cm below the umbilicus. The main outcome measures are the presence of gallstones in patients presenting with umbilical hernia and the presence of umbilical hernia in patients diagnosed with gallstones. Patients with umbilical hernia are examined with biliary ultrasound, while patients with cholelithiasis are evaluated for umbilical hernia by physical examination and ultrasound. Factors such as age, gender, body mass index (BMI), family history, comorbidities, tobacco use, parity, and history of multiple pregnancy are analyzed as potential risk factors.

Conditions

Interventions

DIAGNOSTIC_TEST

Hepatobiliary ultrasound

The presence of cholelithiasis in patients with umbilical hernia is detected by hepatobiliary ultrasound

DIAGNOSTIC_TEST

Umbilical region superficial tissue ultrasound

The presence of umbilical hernia in patients with cholelithiasis is detected by ultrasound of the superficial tissue of the umbilical region.

Sponsors & Collaborators

  • Konya Meram State Hospital

    lead OTHER

Principal Investigators

  • Alpaslan Sahin, MD · Konya Meram State Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-08-31
Completion
2024-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06522308 on ClinicalTrials.gov